GB1057473A - Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof - Google Patents

Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof

Info

Publication number
GB1057473A
GB1057473A GB42651/65A GB4265165A GB1057473A GB 1057473 A GB1057473 A GB 1057473A GB 42651/65 A GB42651/65 A GB 42651/65A GB 4265165 A GB4265165 A GB 4265165A GB 1057473 A GB1057473 A GB 1057473A
Authority
GB
United Kingdom
Prior art keywords
compounds
formula
oxazirino
hydrolysis
benzdiaz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB42651/65A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1057473A publication Critical patent/GB1057473A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compounds of the general Formula (I) <FORM:1057473/C2/1> (wherein the lower alkanoyl and lower alkyl groups each contain 1-7 carbon atoms and the broken lines denote optional substituents) and their acid addition salts are prepared by heating an oxazirino compound of the Formula (II) <FORM:1057473/C2/2> optionally followed by hydrolysis or hydrolysis and lower alkylation, and/or salt formation. The 1-(lower alkanoyl) compounds of Formula (I) are reconverted to the oxazirino compounds on exposure to light. The compounds of the invention are anti-convulsants, and some are tranquilizers and muscle relaxants. They may be administered enterally or parenterally in the form of pharmaceutical preparations (e.g. tablets, drag<\>aees, suppositories, capsules, solutions, emulsions and suspensions) containing them, with or without other (unspecified) active ingredients, together with a carrier.
GB42651/65A 1963-03-26 1964-03-25 Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof Expired GB1057473A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26790863A 1963-03-26 1963-03-26

Publications (1)

Publication Number Publication Date
GB1057473A true GB1057473A (en) 1967-02-01

Family

ID=23020651

Family Applications (3)

Application Number Title Priority Date Filing Date
GB42651/65A Expired GB1057473A (en) 1963-03-26 1964-03-25 Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
GB42650/65A Expired GB1057472A (en) 1963-03-26 1964-03-25 Novel benzdiaz[1,4]epine derivatives and a process for the preparation thereof
GB12628/64A Expired GB1057471A (en) 1963-03-26 1964-03-25 Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB42650/65A Expired GB1057472A (en) 1963-03-26 1964-03-25 Novel benzdiaz[1,4]epine derivatives and a process for the preparation thereof
GB12628/64A Expired GB1057471A (en) 1963-03-26 1964-03-25 Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof

Country Status (11)

Country Link
BE (1) BE645624A (en)
BR (1) BR6457465D0 (en)
CH (1) CH461514A (en)
DE (3) DE1695155A1 (en)
DK (1) DK106911C (en)
ES (1) ES298037A1 (en)
FR (1) FR3276M (en)
GB (3) GB1057473A (en)
IL (2) IL27973A (en)
NL (1) NL6403187A (en)
SE (3) SE312340B (en)

Also Published As

Publication number Publication date
FR3276M (en) 1965-04-26
SE329628B (en) 1970-10-19
BR6457465D0 (en) 1973-07-17
NL6403187A (en) 1964-09-28
IL27973A (en) 1968-07-25
GB1057472A (en) 1967-02-01
IL20920A (en) 1968-07-25
SE329171B (en) 1970-10-05
DE1445890A1 (en) 1969-02-06
DK106911C (en) 1967-04-03
CH461514A (en) 1968-08-31
BE645624A (en) 1964-09-24
DE1695155A1 (en) 1970-07-16
DE1695154A1 (en) 1970-07-16
SE312340B (en) 1969-07-14
GB1057471A (en) 1967-02-01
ES298037A1 (en) 1964-09-01

Similar Documents

Publication Publication Date Title
GB1106040A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
GB1236467A (en) Benzothiazepine derivatives
GB1043049A (en) Benzdiaz [1,4] epinone derivatives, a process for the manufacture thereof and pharmaceutical preparations containing same
GB1142066A (en) New diphenyl-ureas and process for preparing them
ES375203A1 (en) Benzothiazepine derivatives
GB1023793A (en) The manufacture of benzodiazepine derivatives
GB1016071A (en) New guanidine derivatives and process for preparing the same
GB1057473A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
GB1013900A (en) 1,4-benzodiazepine derivatives and a process for the manufacture thereof
GB1252286A (en)
GB1095220A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
GB1112334A (en) Improvements in or relating to isoquinolo[2,1-d]benzo[1,4]diazepine derivatives
GB1116918A (en) A process for the manufacture of benzdiaz[1,4]epine derivatives
ES376688A1 (en) Benzdiazepine derivatives
GB1025577A (en) Benzdiaz[1,4]epine derivatives and the manufacture thereof
GB1369580A (en) Tricyclic diphenylamine derivatives
GB1304098A (en)
GB1000507A (en) Novel benzodiazepine derivatives and a process for the manufacture thereof
GB1028617A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
GB1073521A (en) Indole derivatives
GB1276169A (en) Benzodiazepine derivatives
ES348211A1 (en) 11h-dibenzo(1,2,5)triaz 2 nes and their salts
GB1058738A (en) Benzdiaz[1,4]epines and a process for the manufacture thereof
GB1013453A (en) Novel 1,4-benzodiazepine derivatives and a process for their manufacture
GB1132397A (en) Improvements in or relating to fluorene derivatives and the manufacture thereof